Science Explorer Back to mapMap
Discussion
Researcher · Sun Pharma (United States) · United States

Simon Lowry

Simon Lowry publishes mostly in Immunology, Economics and Econometrics and Surgery, on topics such as Psoriasis: Treatment and Pathogenesis, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical studies and practices.

OpenAlex
World rank
#4,920,461
of 7,710,434 ranked researchers
Rank in United States
#1,282,265
of 1,627,098
Works
24
Citations
282
Citations per work
11.8
h-index
9
i10-index 8Top 80% in Immunology
Simon Lowry

What does Simon Lowry research?

Simon Lowry's work is mostly in Medicine (30%), Immunology and Microbiology (14%), Economics, Econometrics and Finance (11%).

Everything else: 11 works · 45.1% of their workHealth Sciences: 7 works · 29.5% of their workMedicine: 7 works · 29.5% of their workSurgery: 2 works · 8.5% of their workCardiology and Cardiovascular Medicine: 2 works · 7.0% of their workHematology: 2 works · 7.0% of their workRheumatology: 2 works · 7.0% of their workLife Sciences: 3 works · 14.1% of their workImmunology and Microbiology: 3 works · 14.1% of their workImmunology: 3 works · 14.1% of their workSocial Sciences: 3 works · 11.3% of their workEconomics, Econometrics and Finance: 3 works · 11.3% of their workEconomics and Econometrics: 3 works · 11.3% of their workTHEIR WORKSimon Lowry24works
Life Sciences14%Health Sciences30%Social Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1145.1%
    1. Medicine729.5%
    1. Immunology and Microbiology314.1%
    1. Economics, Econometrics and Finance311.3%
  1. 1Immunology14% of their works
  2. 2Economics and Econometrics11% of their works
  3. 3Surgery8% of their works
  4. 4Hematology7% of their works
  5. 5Cardiology and Cardiovascular Medicine7% of their works
  6. 6Rheumatology7% of their works

Research topics

Which keywords describe Simon Lowry's research?

The keywords of their largest research topics: IL-17, TH17 Cells, Cost-effectiveness Analysis, Quality of Life, Inflammation, Off-Label Drug Use, Pediatric Pharmacokinetics and Ankylosing Spondylitis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. IL-17101 topic
  2. TH17 Cells101 topic
  3. Cost-effectiveness Analysis71 topic
  4. Quality of Life71 topic
  5. Inflammation62 topics
  6. Off-Label Drug Use51 topic
  7. Pediatric Pharmacokinetics51 topic
  8. Ankylosing Spondylitis41 topic
  9. Spondyloarthritis41 topic
  10. Cancer31 topic
  11. Cyclooxygenase-2 Inhibitors31 topic
  12. Protease-Activated Receptors31 topic
  13. Thrombin31 topic
  14. Aspirin21 topic
  15. Clopidogrel21 topic
  16. Filaggrin21 topic
  17. Skin Microbiome21 topic

Where does Simon Lowry work?

Simon Lowry's main affiliation in the publication record is Sun Pharma (United States), United States.

How many publications and citations does Simon Lowry have?

OpenAlex counts 24 works and 282 citations for Simon Lowry, an h-index of 9, ranking #4,920,461 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Simon Lowry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.